Pölönen, Petri

Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity

Dufva, O., Koski, J., Maliniemi, P., Ianevski, A., Klievink, J., Leitner, J., Pölönen, P., Hohtari, H., Saeed, K., Hannunen, T., et al. (2020) · Blood

CAR-T cell therapy researchProtein Degradation and Inhibitors

Cited by 224

Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia

Kuusanmäki, H., Leppä, A.-M., Pölönen, P., Kontro, M., Dufva, O., Deb, D., Yadav, B., Brück, O., Kumar, A., Everaus, H., et al. (2020) · Haematologica

Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes

Cited by 186

The genomic basis of childhood T-lineage acute lymphoblastic leukemia

Mullighan, C., Pölönen, P., Giacomo, D. D., Seffernick, A., Elsayed, A., Kimura, S., Benini, F., Montefiori, L., Wood, B., Xu, J., et al. (2023) · Nature

Acute Lymphoblastic Leukemia researchAcute Myeloid Leukemia Research

Cited by 173

The genomic basis of childhood T-lineage acute lymphoblastic leukaemia

Pölönen, P., Di Giacomo, D., Seffernick, A. E., Elsayed, A., Kimura, S., Benini, F., Montefiori, L. E., Wood, B. L., Xu, J., Chen, C., et al. (2024) · Nature

Acute Lymphoblastic Leukemia researchAcute Myeloid Leukemia Research

Cited by 173